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Abstract
Globalisation affects all facets of human life, including health and well being. The HIV/AIDS epidemic
has highlighted the global nature of human health and welfare and globalisation has given rise to a
trend toward finding common solutions to global health challenges. Numerous international funds
have been set up in recent times to address global health challenges such as HIV.
However, despite increasingly large amounts of funding for health initiatives being made available
to poorer regions of the world, HIV infection rates and prevalence continue to increase world
wide. As a result, the AIDS epidemic is expanding and intensifying globally. Worst affected are
undoubtedly the poorer regions of the world as combinations of poverty, disease, famine, political
and economic instability and weak health infrastructure exacerbate the severe and far-reaching
impacts of the epidemic.
One of the major reasons for the apparent ineffectiveness of global interventions is historical
weaknesses in the health systems of underdeveloped countries, which contribute to bottlenecks in
the distribution and utilisation of funds. Strengthening these health systems, although a vital
component in addressing the global epidemic, must however be accompanied by mitigation of other
determinants as well. These are intrinsically complex and include social and environmental factors,
sexual behaviour, issues of human rights and biological factors, all of which contribute to HIV
transmission, progression and mortality. An equally important factor is ensuring an equitable
balance between prevention and treatment programmes in order to holistically address the
challenges presented by the epidemic.
Introduction
Globalisation, narrowly defined by Joseph Stiglitz as "the
removal of barriers to free trade and the closer integration
of national economies." [1], has a much wider sweep and
also affects the political, cultural and social life of popula-
tions across the globe. The health sector is no exception.
As Barnett and Whiteside [2] point out, health and well-
being are international concerns and global goods, and
inherent in the epidemic are lessons to be learned regard-
ing collective responsibility for universal human health.
AIDS is a pandemic of unprecedented pervasiveness,
spreading to the furthest corners of the world. Globalisa-
tion is both midwife to the spread of the disease, as mod-
ern travel facilitates rapid dissemination of HIV infection
across national borders, and, through concerted global
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action, triumphant conqueror over its devastating impact
and expansion. Despite poorer countries having ever
greater access to money, effective and affordable interven-
tions, and technical support, the epidemic continues una-
bated in many of the resource-constrained regions of the
world. A major reason for this continued spread is the
numerous constraints within health systems in develop-
ing countries, which impact upon government policy,
strategic and health policy management and health serv-
ice delivery.
In this paper, we discuss trends in the global AIDS epi-
demic as well as the numerous global funds that are avail-
able to meet the challenges posed by the disease. We also
highlight the need for equal prominence to be given to
both treatment and prevention programmes in the global
fight against HIV/AIDS. Lastly, we examine how bottle-
necks in health systems of developing countries reduce
the effectiveness of such aid and suggest ways in which
these blockages can be eradicated through systematic
strengthening of health systems.
Trends in the global epidemic
Despite increased resources being available to address the
global AIDS challenge, the infection continues to spread.
Table 1 shows the regional progression in HIV infection
rates over the last five years.
HIV prevalence is intensifying in most regions, with sub-
Saharan Africa, Eastern Europe and Central Asia being the
worst hit, accounting for approximately 79% of new infec-
tions between 1998 and 2003. Although the greatest
number of people living with HIV are in sub-Saharan
Africa, of equal concern is the growing epidemic in Cen-
tral Asia [3].
The epidemiology of the disease differs between regions.
It has been suggested that, due to dissimilar patterns of
sexual behaviour between Africa and Asia, the extent of
the spread to the heterosexual population in Asia will be
circumscribed. In most of sub-Saharan Africa, HIV spreads
through an intricate web of relationships from sex work-
ers to male clients to female spouses/partners. According
to Peter Piot of UNAIDS, females in Africa generally report
more sexual partners than their Asian counterparts [4]. In
most of Central Asia transmission is virtually linear, from
intravenous drug users to sex workers to male clients to
female spouses/partners, with women tending to monog-
amy [4]. The next decade will attest to the accuracy or error
of this prediction. Rising prevalence is, however, not con-
fined to developing countries, as an increase in the
number of HIV infections is evident in all other regions
except South and South East Asia (where inconsistencies
in data collection methods have tended to skew the
figures).
Several trends shape the HIV epidemiological curve
• An increasingly mobile global population exacerbates
the risk of HIV transmission. The increasing volume of
international travel contributes to the spread of sexually
transmitted infections, including HIV [5]. Refugee popu-
lations arising from areas of conflict, estimated by the
United Nations High Commission for Refugees to
number 9,7 million worldwide [6], are at higher risk, as
are internal migrants within countries, who oscillate
between rural and urban milieux. According to the Inter-
national Labour Organisation, at the beginning of the
21st century, 120 million workers worldwide were
migrants [7].
• Females are more at risk of contracting HIV than males.
In 1997, women accounted for 41% of people living with
Table 1: Trends in HIV Infections By Region
Region No of people living with HIV 
(end of 1998) [39]
No of people living with HIV 
(end of 2003) [40]
% Increase 1998–2003
Sub-Saharan Africa 22,500,000 25,000,000 11%
South & South-East Asia 6,700,000 6,500,000 -3% 1
Eastern Europe & Central Asia 270,000 1,300,000 381%
Western Europe 500,000 580,000 16%
East Asia 560,000 900,000 61%
Oceania 12,000 32,000 167%
North Africa & Middle East 210,000 480,000 129%
North America 890,000 1,000,000 12%
Caribbean 330,000 430,000 30%
Latin America 1,400,000 1,600,000 14%
TOTAL 33,372,000 37,822,000 13%
1 this apparent decrease is due to inconsistencies in data collection methods between earlier and later years, as well as revised estimates by 
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HIV worldwide. This figure had risen to almost 50% by
2002. This gender-bias is especially apparent in sub-Saha-
ran Africa, where the majority of those infected are
women and girls. Widespread wars and regional conflicts
in Africa escalate, by orders of magnitude, the risk of rape
of women and girls. The low social status of women, risky
sexual practices, and endemic poverty in Africa contribute
to the spread of the disease. The impact on women is less
marked in Asia (where 28% of those infected are women),
although women's low socio-economic status renders
them more susceptible to infection. Women's increased
vulnerability to HIV infection is not confined to develop-
ing countries. Between 2001 and 2003, the percentage of
HIV-infected who are women increased in North America
from 20% to 25%, and in Oceania from 17% to 19%, sug-
gesting that gender inequalities underpin the transmis-
sion of HIV [8].
• The impact of HIV mortality is greatest on people in
their 20's and 30's; this severely distorts the shape of the
population pyramid in affected societies. Projections indi-
cate that mortality rates will increase: The UN predicts
that, in seven selected countries in sub-Saharan Africa, 14
million AIDS-related deaths will occur between 1995 and
2025 [9]. UNAIDS projections indicate that, unless the
AIDS response is greatly increased, populations in 38 Afri-
can countries will decrease by 14% by 2025 [8].
• In sub-Saharan Africa, it is estimated that 12 million
children have lost one or both parents to AIDS, a figure
which is expected to increase to 18 million by 2010. Even
in countries where HIV infections have plateaued, the
number of orphans continues to rise due to the time lapse
between infection and death of parents [8].
• Agricultural output, the cornerstone of production in
agrarian economies, is decreasing as a result of increased
mortality in the workforce, resulting in what has been
termed "new-variant famine". Studies predict that in the
ten most severely affected African countries, the agricul-
tural workforce will decline by 10–26% by 2020 [9]. Ber-
tolt Brecht ascribed these disasters to human greed and
folly: "Famines do not simply occur – they are organized
by the grain trade." New-variant famine, however, is the
consequence of the mutually reinforcing intercessions of
human frailty and a social disease. The former from a pau-
city of timeous responses to the epidemic by the ruling
classes, aggravated by communities steeped in stigma, fear
and discrimination, and the latter from a mix of biology
and human propensity to risky sexual behaviour. The
combination of lost production and resulting malnutri-
tion increase susceptibility to disease [10].
• The macroeconomic repercussions of the epidemic vary,
depending on the industries underpinning the economy
and degree of HIV prevalence. UNAIDS postulates that
any deceleration in economic growth (as measured by
Gross Domestic Product) will be offset by similar reduc-
tions in population numbers due to increased mortality
and therefore resource consumption [8]. A faster decline
in population size relative to GDP should theoretically
result in an increase in per capita GDP. Econometric
research, however, has shown that AIDS has either an
insignificant impact on per capita GDP, or actually
decreases it [11]. The qualitative effects of higher mortal-
ity are also considerable: the erosion of social and intellec-
tual capital and decreased investment in populations of
the future have far-reaching consequences for society as a
whole [9].
• The major economic impact is microeconomic. Individ-
ual households are primarily responsible for coping with
the repercussions of AIDS, and as such bear the brunt of
the epidemic. This translates into increased healthcare
expenses, funeral charges and education costs for house-
holds. In areas where stigma prevails, the psychological
impacts of the disease increase the burden.
• Impact on the workplace is also considerable, translat-
ing into productivity losses and increased costs to employ-
ers due to staff illnesses and deaths, higher health
insurance premiums and low morale [8]. In addition,
household demand for goods and services may decline
due to lower income and levels of consumption, resulting
in the contraction of resource production [9].
Table 2 shows in summary the demographic impacts of
the epidemic, while Table 3 shows the impacts on various
other aspects of society. The ramifications of an epidemic
of this nature and scale will be felt long after incidence of
the disease has peaked, predicted in the case of HIV to be
in 2040 [12]. By way of comparison, the consequences of
the Black Death (1347 – 1351) extended far beyond the
life of the epidemic itself, exerting influence for about 150
years in Europe [13]. In order to mitigate these effects,
massive investments in prevention, treatment and care
programmes and in broad development initiatives must
be given priority.
Global funds
Various global initiatives and collaborations are address-
ing the global HIV/AIDS challenge. For example, the
United Nations Millennium Development Declaration,
signed in 2000 by 189 nations, encompasses eight Millen-
nium Development Goals (MDGs), three of which are
health related: reducing child mortality, improving mater-
nal health, and combating HIV/AIDS, malaria and other
diseases, by 2015 [14]. Many international organizations
have been set up to assist in funding and implementing
HIV prevention and care programmes and related healthGlobalization and Health 2005, 1:13 http://www.globalizationandhealth.com/content/1/1/13
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initiatives worldwide. These include the President's Emer-
gency Plan For AIDS Relief (PEPFAR); the Global Fund to
fight AIDS, Tuberculosis and Malaria; RollBack Malaria,
the Global Alliance for Vaccines and Immunization; the
Global Health Council; Médecins sans Frontiers; the Bill
and Melinda Gates Foundation; the World Bank Multi
Country HIV/AIDS Programme (MAP); the Accelerating
Access Initiative and the William J. Clinton Presidential
Foundation. These organizations contribute increasing
amounts of money to confront AIDS and other pressing
global health issues. UNAIDS [8] reports that in 1996,
approximately US$330 million was available for HIV/
AIDS initiatives worldwide, a figure which had risen to
US$4.7 billion by 2003. Although this represents a huge
increase in funding, it is still less than half the amount of
US$12 billion that is now required, and this exigency is
expected to rise to US$20 billion by 2007.
Despite the large amount of aid being made available in
addressing the AIDS epidemic, shortfalls in both money
and numbers of people being reached are apparent. Of the
estimated 6 million people in developing countries who
are in need of ART, only 400,000 currently receive it. Of
these, 208,000 are in Brazil alone [15]. Even if the World
Table 2: Summary of demographic impacts of AIDS
Demography [9] Without AIDS With AIDS Without AIDS With AIDS Without AIDS With AIDS
1995 – 2000 2010 – 2015 2020 – 2025
Life expectancy at birth (years) 63.9 62.4 68.4 64.2 70.8 65.9
Number of deaths (millions) 159 170 174 207 193 231
Crude death rate per 1,000 9.0 9.6 8.1 9.8 8.0 10.1
Infant mortality rate per 1,000 66.4 67.5 49.8 51.3 40.9 42.1
Child mortality rate per 1,000 93.9 98.8 68.9 75.8 56.1 62.3
Population size (millions) 3666 3639 4310 4204 4805 4599
1,UNAIDS Population Division, 2003
Table 3: Summary of sectoral impacts of AIDS
GDP [41, 42] • Annual decrease of between 2 and 4% with AIDS
Households [9] • Decreased household income • Increased expenditure on healthcare
• More women and child-headed households
• More vulnerable to poverty
Firms [9] • Increased healthcare costs
• Greater absenteeism
• Loss of skilled labour and institutional memory
• Decreased demand for goods → decreased income
• Lower staff morale → lower productivity
Agriculture [9] • Loss of agricultural workforce:
• reduction in cultivated land → decreased yields
• smaller harvest size and less crop variety
• loss of agricultural knowledge
• lower remittances sent home
Education [9] • Loss of teachers → reduction in supply and quality of educational facilities and services
• Increased medical and staff training costs
• Reduction in pupil numbers due to non-enrolment /sickness/deaths
• Reversal in progress made in primary education
Health [9] • Absenteeism and deaths of health workers due to illness:
• reduction in supply and quality of health services
• increased training costs
• erosion of knowledge base
• Quality of care may suffer due to stigmatisation of HIV+ patients
• Increased public health expenses → higher burden on private health care system
• Increased demand for donor funding to address HIV/AIDS challenge
• High demand for AIDS treatment crowds out treatment of other diseases
2Dixon, McDonald and Roberts (2002); Cornia and Zagonaria (2002)Globalization and Health 2005, 1:13 http://www.globalizationandhealth.com/content/1/1/13
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Health Organization's '3 by 5' effort, which aims to pro-
vide treatment to 3 million people by the end of 2005, is
successful, it will have addressed only 50% of the demand
for treatment at the current level of need. The MDGs are
unlikely to be met at the current rates of progress, with the
worst affected countries likely to make the least headway.
Another issue of concern is that the focus of many of these
programmes is on treatment rather than prevention of
HIV. Initiatives geared to increasing the delivery of treat-
ment to developing countries has increased substantially
since 2001, when the Declaration of Commitment on
HIV/AIDS was signed by 189 member states of the United
Nations [16]. For example:
• The Global Fund to fight AIDS, Tuberculosis and
Malaria has approved funding for the provision of antiret-
roviral therapy (ART) to 700,000 people [17].
• The World Bank plans to increase financial assistance for
ART programmes in eligible countries [17].
• PEPFAR's focus is largely on treatment [18] and plans to
deliver ART to 2 million people in sub-Saharan Africa and
the Caribbean by 2007 [17].
• The focus of the WHO's "3 by 5" programme is also
exclusively on the treatment of HIV [15].
Current data suggests that approximately 33% of funding
for AIDS initiativesbe allocated for treatment and care,
with approximately 51% for prevention programmes
[19]. Schwartländer et al [20] advocate a similar split in
fund allocation between treatment and care on the one
hand, and prevention initiatives on the other.
During the early stages of the epidemic, programmes
designed to prevent HIV had rightly been the prime
endeavour of poorer countries; indeed there was little else
on offer. Even when the prospects of effective specific
antiretroviral treatment improved after 1996, many
scientists and health professionals remained committed
to a dominant role of prevention over treatment and care.
Prevention services, they believed, were not restricted to
prophylaxis but included palliative care and the manage-
ment of opportunistic infections. The latter were inexpen-
sive and cost-effective; the concern was that highly active
antiretroviral therapy (HAART), being more costly, would
drain money from prevention programmes. But the direct
and indirect financial, social, economic, political and
security costs of failing to introduce effective prevention
measures are undeniably very high. Based on figures from
previous studies [21], Marseille et al modelled the cost-
effectiveness of HAART against cotrimoxazole prophy-
laxis, and found that the ratio between the cost-effective-
ness of HAART and prevention is US$350:US$12.50. (a
ratio of 28:1). In human terms, for every life-year gained
through HAART, 28 life-years could have been gained
through prevention [22].
Marseille's evaluation, however, disregards the synergy
between prevention and treatment interventions. Preven-
tion, although an important component in addressing the
epidemic, is inadequate in isolation. The low rates of
uptake of preventive measures in many developing coun-
tries, which we discuss later, do not diminish this
assertion. In addition to prevention programmes, the pro-
vision of HAART is not only financially feasible, but mor-
ally imperative. The difficulties associated with
introducing ART are well known: there is no eradication of
the virus, therefore treatment is lifelong; adherence lapses
occur; drug formulations are not optimised; drug toxici-
ties are frequent; drug-drug interactions complicate man-
agement and drug resistance requires special attention. In
addition, there are aspects of HAART management which
are still not settled – optimal start time and regimen
sequence, the meaning of regime failure, and the sustain-
able reduction of resistance. The World Health Organiza-
tion argues that the provision of ART, through its ability
to prolong life and alleviate fears about HIV, can both
change attitudes to the disease and, in combination with
prevention, greatly reduce HIV transmission. It is sug-
gested that resource-constrained countries such as Sen-
egal, Thailand and Brazil, which introduced HAART early,
are also the countries with the greatest success in control-
ling the epidemic. A 70% decline in AIDS-related deaths
in affluent countries, where ART is available to the major-
ity of the population, is cited to support this assertion
[15].
It is becoming apparent that the advantages of ART might
be offset by factors which may, on balance, fail to prevent
or reduce transmission of the virus. These include disinhi-
bition of risky sexual behaviour, the spread of drug-resist-
ant strains, and an increased risk of exposure to HIV due
to the improved survival rates of infected persons. In the
context of the developing world, these putative negative
impacts are likely exacerbated for several reasons:
• Early detection of HIV is rare. Patients tend to present in
a state of advanced disease when viral load is high and the
patient is very ill. This usually follows a period of relative
good health during which maximal sexual activity and
consequent high transmission of virus has occurred.
• Provision of ARVs may reduce condom use [17]
• ART efficacy may diminish as successive ARV regimes are
used [23]Globalization and Health 2005, 1:13 http://www.globalizationandhealth.com/content/1/1/13
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Despite these inherent hazards, given the continued esca-
lation in HIV infections worldwide, it is reasonable and
compassionate to attempt to achieve synergies between
HAART and prevention services through their simultane-
ous implementation.
UNAIDS has identified a comprehensive list of preven-
tion, treatment and care services which define standard
services for HIV/AIDS control (Table 4). Most of these
interventions are affordable by poor countries, either
through their own budgets or from donor funds. A key
issue is incorporation of applicable interventions into
existing health services and programmes.
Health systems capacity
An over-reliance on donor funds can reduce the long-term
sustainability of aid programmes, and the reduced
absorptive capacity of recipient countries for such assist-
ance often results in bottlenecks, preventing aid packages
from being used where they are most needed. As a result,
despite higher levels of acceptance of AIDS by certain gov-
ernments, a global climate of increased political stability
and economic growth, and greater public access to infor-
mation and advocacy, inequitable access to treatment and
prevention persists. While challenges experienced by
households and communities in terms of providing
resources for home-based care are also significant hin-
drances to the effective delivery of care, shortcomings
inherent in health systems constitute the major blocks in
channeling ever-increasing amounts of aid to those most
in need. It follows that inequities in the provision of
healthcare services may escalate in the coming years
unless efficiency is coupled with justice in the construc-
tion of national health systems.
Constraints relating to supply within health systems,
including finance, information systems, human resources,
drugs and logistics [14], as well as those on the demand-
side, such as increased patient numbers, and stigma and
discrimination among communities [8], hinder progress.
The example of introducing prevention of mother to child
transmission (PMTCT) programmes, which are among
the simplest and most cost-effective of anti-HIV pro-
grammes available, into national health systems, is illus-
trative of the challenges faced by developing countries.
Single dose Nevirapine (a dose each to mother during
delivery and to her newborn) is the most widely used reg-
imen for PMTCT, having the advantages of simplicity,
affordability, and effectiveness. Most programmes and
agencies, including UNICEF, the Elizabeth Glaser Pediat-
ric AIDS Foundation (EGPAF), and state authorities, have
found that in developing countries, of the women who
should be given ART, only a minority receive the drugs.
Even fewer infants are given their prophylactic dose of
Nevirapine. Until recently, experience suggested that,
despite wide variations between countries, in general, of
the HIV positive women attending antenatal clinics, prob-
ably < 20% received ARVs. Neff Walker [24] has estimated
that, of the 2.1 million pregnant women who are HIV pos-
itive in any given year globally (excluding high-income
countries), only 200,000 receive PMTCT interventions.
Current information from some centres, however, sug-
gests that uptake is improving. Data from studies under-
taken in Kwazulu Natal, South Africa – a region severely
affected by the epidemic – show that, for 150,000 deliver-
ies per annum, PMTCT coverage increased from 10% in
2001 to 78% in 2003/04 (Figure 1) [25]. Reasons for such
improvements in a number of countries may be attributed
to:
• Increased awareness of HIV due to the expansion of edu-
cation, information and communication programmes,
which results over time in increased acceptance of the dis-
ease and its implications. This in turn fosters greater com-
Table 4: Standard HIV/AIDS Interventions used by UNAIDS to 
measure resource needs and resource availability in low-and 
middle-income countries
Prevention Interventions
1. Mass media campaigns
2. Voluntary counseling and testing (VCT)
3. Condom social marketing
4. School-based AIDS education
5. Peer education for out-of-school youth
6. Outreach programmes for sex workers and their clients
7. Outreach programmes for men who have sex with men
8. Harm-reduction programmes for injecting users
9. Blood safety
10. Public sector condom promotion and distribution
11. Treatment of sexually transmitted infections
12. Workplace prevention programmes
13. Prevention of mother-to-child transmission
14. Post-exposure prophylaxis (PEP)
15. Safe injections
16. Universal precautions
17. Policy, advocacy, administration and research
Care Services
1. Palliative care
2. Diagnosis of HIV infection (HIV testing)
3. Treatment for opportunistic infections
4. Prophylaxis for opportunistic infections
5. Antiretroviral (ARV) therapy, including laboratory services for 
monitoring treatment
Orphan Support
1. Community support for orphan care
2. Orphanages
3. School fee support for orphans
UNAIDS, 2003Globalization and Health 2005, 1:13 http://www.globalizationandhealth.com/content/1/1/13
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munity mobilisation in providing support groups, home-
based care initiatives, orphan care and food aid.
• More rapid and reliable testing methods, including 'opt-
out' options, better counseling programmes and facilities,
and the inclusion of partners in both testing and coun-
seling programmes
• Enhanced record keeping, including improved identifi-
cation systems for both mothers and infants.
• Advances in drug technology and therapies with result-
ant wider availability of ARVs for both mothers and
infants.
Figure 2, taken from the same study, shows that despite
this increase, only 59% of women attending antenatal
clinics who test HIV-positive actually receive Nevirapine.
Much of this attrition is due to failing health systems,
although other factors, such as stigma and discrimination,
also have an effect on poor uptake.
Health system reform
The World Health Report (2004) states that "The 3 by 5
initiative...cannot be implemented in isolation from a
regeneration of health systems." [26]. Several studies sup-
port this statement, reflecting the unfavourable condi-
tions in the health care systems of developing regions
[27,28].
UNAIDS [8] suggests that, in order to build capacity, an
approach which incorporates training, technical assist-
ance and access to improved guidelines and tools should
be adopted by funders. In order to utilize resources effec-
tively recipient countries need to undertake thorough
planning processes whereby goals relevant to that country
are set and allocation of funds is made according to need
[29,30].
However, constraints may have multiple causes, both
within and external to the health system itself, which may
themselves be interdependent. Two approaches to over-
coming constraints may be identified: dealing with con-
straints specific to the disease across all aspects of the
health system, or addressing specific weaknesses in the
health system across all diseases. It has been argued that
disease-specific programmes can build skills and develop
effective management structures to allow health services
to cope with the demands placed on them [31]. The scale
and nature of the HIV epidemic is such that it is generally
the most pressing health challenge faced by developing
countries. As such, an approach specific to the disease
itself could be seen as the most effective way of building
the capacity of health systems in countries of need, as it
may be a more manageable way to address weaknesses in
the health system while at the same time delivering short-
term returns. This approach can, however, result in paral-
lel systems being set up, and can cause disruptions in day
to day healthcare provision. There are multiple overlaps in
the health service requirements for HIV/AIDS and those
Coverage of PMTCT Programme in Kwazulu Natal, South Africa between 2001 and 2004 Figure 1
Coverage of PMTCT Programme in Kwazulu Natal, South Africa between 2001 and 2004. Kwazulu Natal Dept of 
Health (2004)Globalization and Health 2005, 1:13 http://www.globalizationandhealth.com/content/1/1/13
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for other diseases, which constitute a compelling argu-
ment to avoid as far as possible vertical schemes for HIV
prevention and treatment interventions. For example,
PMTCT programmes cannot be isolated from adequate
antenatal clinic services, family planning, delivery facili-
ties, and ambulatory services for chronic diseases of
women and children. Indeed, the inclusion of male part-
ners as an essential component in PMTCT-Plus indicates
the broad sweep of interconnected services necessary. The
frequent coinfections between HIV and tuberculosis are
persuasive reasons for seeking complementarity between
services for each. A system-wide response has the advan-
tage that constraints addressed benefit a range of diseases,
and draws attention to other health challenges that may
be overlooked in the context of HIV/AIDS. Although the
results of this approach may not be as quickly seen as in
the disease-specific approach, it allows the system in its
entirety to be strengthened.
It follows that the health system, rather than the specific
disease, should be tackled in order to achieve the effective
and holistic delivery of interventions. Such restructuring
tends to be effective only in the long term, so immediate
interventions may have to be introduced into the health
system to deal with the pressing needs of prevention and
of HIV/AIDS patients.
Robust health systems play a fundamental role in chan-
nelling globally recognised prevention and treatment best
practice for the mitigation of HIV/AIDS. However, certain
social and biological complexities profoundly affect the
transmission, progression and mortality of the disease;
these lie beyond the scope of health services. Intrinsically
difficult to control, these elements constitute significant
obstacles to the prevention and management of the HIV/
AIDS epidemic. Biological factors, such as exposure to
infected individuals (through sex, contaminated blood
products, or perinatally), infectivity (determined by the
viral load), and concomitant sexually transmitted infec-
PMTCT Uptake at maternity hospitals, clinics and community health centres in Kwazulu Natal, South Africa (June 2001 –  August 2004) Figure 2
PMTCT Uptake at maternity hospitals, clinics and community health centres in Kwazulu Natal, South Africa 
(June 2001 – August 2004). Kwazulu Natal Dept of Health (2004)Globalization and Health 2005, 1:13 http://www.globalizationandhealth.com/content/1/1/13
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tions (STIs) greatly increase susceptibility to infection.
Social and environmental determinants, which include
socio-economic status (for example, unemployment, pov-
erty, degree of urbanisation and migration) may increase
proclivity to risky behaviour (such as unprotected sex or
drug use) and heighten the possibility of infection.
Another important factor here is gender and age: women's
lower status and adolescents' relative youth renders both
groups more vulnerable to infection due in part to a con-
sequent lack of power in relationships. [32-38].
It follows therefore that addressing health system con-
straints alone will not constitute a comprehensive solu-
tion to the management of the epidemic. Mitigation of
risk factors needs to be an integral part of the response to
HIV/AIDS in order for real progress to be made in the pro-
pitiation of the disease.
Conclusion
The expansion of the AIDS epidemic across the globe has
galvanized the global community into demonstrating a
willingness to challenge its unabated spread. The increas-
ing mobilisation of resources aimed at mitigating the
impact of the disease in developing regions of the world
in particular holds numerous potential benefits on the
course of the AIDS epidemic. Whether these benefits are
realized or not depends on resources dedicated to address-
ing the global AIDS challenge being received by those in
need.
The large volumes of aid being made available to develop-
ing countries has in many instances resulted in bottle-
necks in health systems in these regions, which are
historically unable to cope with the demands being place
upon them by the accelerating spread of HIV and concom-
itant influx of resources to meet this challenge. Effective
delivery of aid is thus hampered. This problem can be
addressed through systemic strengthening of health sys-
tems in order to build capacity and sustainability, thereby
redressing the inequities in healthcare delivery due to his-
torical differences in health systems between and within
rich and poor countries. However, other risk factors such
as behaviour, socio-economics and biology also contrib-
ute to the spread of the disease. It follows that addressing
both health systems and these external factors is necessary
in order to manage and contain HIV comprehensively.
Another important factor in the management of the epi-
demic is the balance between prevention and treatment
programmes. The present apparent emphasis on treat-
ment to the detriment of prevention needs to be redressed
in order to meet the challenges of the disease at all levels.
Globalisation brings with it many benefits in addressing
the spread of HIV throughout the world. However, these
benefits can only be realized if appropriate programmes
are available in areas of need. As part of the generous sup-
ply of aid aimed at addressing problems specific to HIV/
AIDS, attention needs to be paid to building capacity in
recipient countries so that such funds may be effectively
disseminated and the epidemic effectively curbed.
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